Literature DB >> 22162568

Insulin- and obesity-related variables in early-stage breast cancer: correlations and time course of prognostic associations.

Pamela J Goodwin1, Marguerite Ennis, Kathleen I Pritchard, Maureen E Trudeau, Jarley Koo, Sara K Taylor, Nicky Hood.   

Abstract

PURPOSE: To investigate patterns of prognostic associations over time of insulin- and obesity-related variables measured at diagnosis of early breast cancer (BC), focusing on whether the prognostic associations with distant recurrence and death changed over time. PATIENTS AND METHODS: Five hundred thirty-five nondiabetic women with T1-3, N0-1, M0 invasive BC diagnosed from 1989 to 1996 were included in the study. Insulin-related variables included fasting insulin, Homeostasis Model Assessment, C-peptide, and glucose. Obesity-related variables included weight, body mass index (BMI), waist and hip circumference, and leptin. Correlations were examined using the Pearson correlation coefficient and prognostic associations using the Cox model.
RESULTS: There was evidence that associations of baseline insulin-related variables with distant recurrence and death were not constant over time; univariable adverse prognostic associations were significant only during the first 5 years (eg, insulin quartile 4 v 1: hazard ratio [HR], 2.32; 95% CI, 1.39 to 3.86; P < .001 for distant disease-free survival [DDFS]; and HR, 2.85; 95% CI, 1.48 to 5.50; P = .002 for overall survival [OS], with little attenuation of this pattern in multivariable analyses). In contrast, obesity-related variables (BMI, weight, leptin) exerted significant adverse univariable associations that were constant over time (eg, BMI quartile 4 v 2: HR, 1.40; 95% CI, 1.07 to 1.82 for DDFS; P = .014; and HR, 1.50; 95% CI, 1.16 to 1.93; P < .001 for OS); prognostic associations of leptin remained significant in multivariable analyses.
CONCLUSION: Baseline insulin- and obesity-related variables exert different patterns of prognostic associations over time in early BC.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22162568     DOI: 10.1200/JCO.2011.36.2723

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  87 in total

Review 1.  Potential applications for biguanides in oncology.

Authors:  Michael Pollak
Journal:  J Clin Invest       Date:  2013-09-03       Impact factor: 14.808

Review 2.  Adipokine leptin in obesity-related pathology of breast cancer.

Authors:  Amitabha Ray
Journal:  J Biosci       Date:  2012-06       Impact factor: 1.826

3.  Body mass and smoking are modifiable risk factors for recurrent bladder cancer.

Authors:  Asaf Wyszynski; Sam A Tanyos; Judy R Rees; Carmen J Marsit; Karl T Kelsey; Alan R Schned; Eben M Pendleton; Maria O Celaya; Michael S Zens; Margaret R Karagas; Angeline S Andrew
Journal:  Cancer       Date:  2013-10-10       Impact factor: 6.860

4.  Risk of breast cancer recurrence associated with carbohydrate intake and tissue expression of IGFI receptor.

Authors:  Jennifer A Emond; John P Pierce; Loki Natarajan; Laarni R Gapuz; John Nguyen; Barbara A Parker; Nissi M Varki; Ruth E Patterson
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-04-22       Impact factor: 4.254

5.  The effect of aerobic exercise on metabolic and inflammatory markers in breast cancer survivors--a pilot study.

Authors:  E Guinan; J Hussey; J M Broderick; F E Lithander; D O'Donnell; M J Kennedy; E M Connolly
Journal:  Support Care Cancer       Date:  2013-02-22       Impact factor: 3.603

6.  The Yale Fitness Intervention Trial in female cancer survivors: Cardiovascular and physiological outcomes.

Authors:  M Tish Knobf; Sangchoon Jeon; Barbara Smith; Lyndsay Harris; Siobhan Thompson; Mitchel R Stacy; Karl Insogna; Albert J Sinusas
Journal:  Heart Lung       Date:  2017-08-10       Impact factor: 2.210

Review 7.  Circulating adiponectin and breast cancer risk: a systematic review and meta-analysis.

Authors:  Debora Macis; Aliana Guerrieri-Gonzaga; Sara Gandini
Journal:  Int J Epidemiol       Date:  2014-04-15       Impact factor: 7.196

8.  Industry is not the dark side, but an essential partner to make progress in reproductive health.

Authors:  Thomas D'Hooghe
Journal:  Womens Health (Lond)       Date:  2016-03-03

9.  Improving health engagement and lifestyle management for breast cancer survivors with diabetes.

Authors:  Rebecca A Shelby; Caroline S Dorfman; Sarah S Arthur; Hayden B Bosworth; Leonor Corsino; Linda Sutton; Lynda Owen; Alaattin Erkanli; Francis Keefe; Cheyenne Corbett; Gretchen Kimmick
Journal:  Contemp Clin Trials       Date:  2020-04-11       Impact factor: 2.226

10.  Effect of body mass index on tumor characteristics and disease-free survival in patients from the HER2-positive adjuvant trastuzumab trial N9831.

Authors:  Jennifer A Crozier; Alvaro Moreno-Aspitia; Karla V Ballman; Amylou C Dueck; Barbara A Pockaj; Edith A Perez
Journal:  Cancer       Date:  2013-04-12       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.